Table 2:
Characteristic | No. (%) of respondents* | |
---|---|---|
Patients n = 38 |
Nonpatients n = 21 |
|
Age, yr, mean ± SD | 38 ± 8 | 46 ± 9† |
Sex | ||
Female | 34 (89) | 16 (76) |
Male | 4 (11) | 5 (24) |
Category | ||
Parent | 24 (63) | NA |
Parent and survivor | 2 (5) | NA |
Survivor | 8 (21) | NA |
Parent and spouse of survivor | 2 (5) | NA |
Family | 1 (3) | NA |
Unaffected RB1 mutation carrier and parent | 1 (3) | NA |
Clinician | NA | 16 (76) |
Ophthalmologist | NA | 5 (24) |
Oncologist | NA | 4 (19) |
Genetic counsellor | NA | 3 (14) |
Child life specialist | NA | 2 (10) |
Molecular geneticist | NA | 1 (5) |
Social worker | NA | 1 (5) |
Clinician-scientist | NA | 3 (14) |
Ophthalmologist | NA | 2 (10) |
Medical geneticist | NA | 1 (5) |
Researcher | NA | 2 (10) |
Laterality | ||
Bilateral | 26 (68) | NA |
Unilateral | 11 (29) | NA |
Not provided | 1 (3) | NA |
Place of residence | ||
Ontario | 22 (58) | 12 (57) |
Alberta | 11 (29) | 2 (10) |
New Brunswick | 1 (3) | 0 (0) |
Quebec | 1 (3) | 3 (14) |
Nova Scotia | 0 (0) | 2 (10) |
Not provided | 3 (8) | 2 (10) |
Note: NA = not applicable, SD = standard deviation.
Except where noted otherwise.
n = 20.